Pharmaceuticals Company Investment Opportunity in Delhi, India
- Annual capacity of 300MT to manufacture Sterile API.
- Having world class R&D setup recognized by DST, GOI.
- Well-established clientele in India and also export its product to Asia pacific regions, North Africa, South America etc.
- Having various FDA approval such as Schedule M, FDA Govt. of India, WHO GMP, ANVISA GMP.
- Having 2 dedicated manufacturing units.
Bulk Sterile API.
Proton Pump Inhibitors.
General Formulation such as - Acyclovir for injection 500mg / vial, Ketoprofen for injection 100mg / vial etc.
Earlier than 15 daysCoordinator, Investments & Finance, Vilnius, Corporate Investor / Buyer connected with this business
Earlier than 15 daysDirector, Mumbai, Financial Consultant connected with this business
Earlier than 15 daysAssociate Vice President, Delhi, Financial Advisor connected with this business